Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash 99 tok/s
Gemini 2.5 Pro 48 tok/s Pro
GPT-5 Medium 36 tok/s
GPT-5 High 40 tok/s Pro
GPT-4o 99 tok/s
GPT OSS 120B 461 tok/s Pro
Kimi K2 191 tok/s Pro
2000 character limit reached

PRISM2: Unlocking Multi-Modal General Pathology AI with Clinical Dialogue (2506.13063v1)

Published 16 Jun 2025 in cs.CV and cs.CL

Abstract: Recent pathology foundation models can provide rich tile-level representations but fall short of delivering general-purpose clinical utility without further extensive model development. These models lack whole-slide image (WSI) understanding and are not trained with large-scale diagnostic data, limiting their performance on diverse downstream tasks. We introduce PRISM2, a multi-modal slide-level foundation model trained via clinical dialogue to enable scalable, generalizable pathology AI. PRISM2 is trained on nearly 700,000 specimens (2.3 million WSIs) paired with real-world clinical diagnostic reports in a two-stage process. In Stage 1, a vision-LLM is trained using contrastive and captioning objectives to align whole slide embeddings with textual clinical diagnosis. In Stage 2, the LLM is unfrozen to enable diagnostic conversation and extract more clinically meaningful representations from hidden states. PRISM2 achieves strong performance on diagnostic and biomarker prediction tasks, outperforming prior slide-level models including PRISM and TITAN. It also introduces a zero-shot yes/no classification approach that surpasses CLIP-style methods without prompt tuning or class enumeration. By aligning visual features with clinical reasoning, PRISM2 improves generalization on both data-rich and low-sample tasks, offering a scalable path forward for building general pathology AI agents capable of assisting diagnostic and prognostic decisions.

List To Do Tasks Checklist Streamline Icon: https://streamlinehq.com

Collections

Sign up for free to add this paper to one or more collections.

Summary

We haven't generated a summary for this paper yet.

Dice Question Streamline Icon: https://streamlinehq.com

Follow-up Questions

We haven't generated follow-up questions for this paper yet.

X Twitter Logo Streamline Icon: https://streamlinehq.com